Cardiovascular Disease Doctors in Laurinburg, NC - Medicare Status, Address, Contact

1 Cardiovascular Disease doctors found. Showing 1 - 1

Dr. Matthew Block, MD
Internal Medicine - Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1601 Medical Dr, Laurinburg, NC 28352
Phone: 910-277-7858 Fax: 910-277-8286

News Archive

Samoa measles epidemic escalates as death toll reaches 32

The deadly measles epidemic sweeping the Pacific islands has now claimed 32 lives in Samoa, according to the health authorities.

New commentary documents harmful effects of sequestration on Indian Health Service

As federal legislators work toward a budget agreement, a new commentary documents the harmful effects of sequestration on the Indian Health Service. Sequestration forced a 5 percent reduction in funds for the Indian Health Service, perpetuating longstanding health care disparities and raising questions about the federal government's legal and moral obligation to Indians, states the commentary, which appears in the Hastings Center Report.

Study points to major role of obesity in triggering, prolonging autoimmune diseases

Autoimmune diseases like Crohn's Disease and multiple sclerosis, in which the immune system attacks its own body rather than predatory invaders, affect 5-20% of the global community. A study published recently in Autoimmunity Reviews by Prof. Yehuda Shoenfeld, the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases at Tel Aviv University's Sackler Faculty of Medicine and Head of Zabludowicz Center for Autoimmune Diseases at Chaim Sheba Medical Center, Tel Hashomer, points to the major role obesity plays in triggering and prolonging these autoimmune diseases.

FDA extends PDUFA action date for NPS Gattex NDA

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has received a communication from the U.S. Food and Drug Administration extending the Prescription Drug User Fee Act action date for its New Drug Application for Gattex (teduglutide) by three months to December 30, 2012.

Phase IIb Aviator study demonstrates high SVR rates against genotype 1 HCV

Results from "Aviator," AbbVie's phase IIb clinical trial of its investigational direct-acting antivirals for the treatment of hepatitis C virus infection, continue to demonstrate high sustained viral response rates against genotype 1 HCV, across patient types.

Cardiovascular Disease Doctors in Laurinburg, NC Accepting Medicare